Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences
about
Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer ProgressionParadigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesisMechanisms involved in breast cancer liver metastasisClaudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activationModelling circulating tumour cells for personalised survival prediction in metastatic breast cancerLyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implicationsThe role of claudins in cancer metastasis.Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes.Claudin proteins, outside-in signaling, and carcinogenesis.Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation.HCMDB: the human cancer metastasis database.Comprehensive characterization of differentially expressed genes in thyroid cancer.Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model.Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer.
P2860
Q26768428-FBE6B8A3-BF5E-4CBF-ACE0-8D297157B54DQ26787279-807DD0AC-C907-4C50-B438-C701A463B3BEQ28084024-95A7EFDB-F3AD-4B7A-9FE6-9A73C9D81DBFQ33618564-974823D1-FBBE-4959-8EAE-A1CC349484FFQ35610546-B1D67528-E0A8-438F-BECF-A52CA61B1752Q35832402-B40CAAB5-6DF9-4B3C-BD88-6A9319AD97BCQ36545146-01E4268F-7901-4D03-AEEA-8C733BD26743Q38927656-1EE60314-ADA5-497A-8891-1BB414C9DF47Q38931957-4E754905-9323-48B2-810D-2E806141FEE5Q39042347-5DA808A6-3082-4C40-9B60-C6D89336EB0AQ42509993-8F67F7C6-41AC-4117-9443-595ABD46B09AQ45327665-7BF9ABBF-D010-4480-9818-BC2E502126E3Q47110361-AF688CCD-AB62-464D-BD8E-A5C2A8017B50Q47687862-EAD9A0BB-2534-404E-AF02-AAFF0273516EQ51805406-5C8FB732-3FB1-40C6-9F1E-758CF7DA47F6Q55691533-2C1C46ED-8EED-4B4D-96CA-CAA6AB8014D3
P2860
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Claudin-2 is an independent ne ...... edicts early liver recurrences
@en
type
label
Claudin-2 is an independent ne ...... edicts early liver recurrences
@en
prefLabel
Claudin-2 is an independent ne ...... edicts early liver recurrences
@en
P2093
P2860
P1433
P1476
Claudin-2 is an independent ne ...... edicts early liver recurrences
@en
P2093
Anikó Kovács
Mårten Fernö
Pär-Ola Bendahl
Siker Kimbung
Thomas Hatschek
P2860
P304
P356
10.1016/J.MOLONC.2013.10.002
P577
2013-10-14T00:00:00Z